Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ddccff8a674aa35f1bd0ae4b9a05b920 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c2136be309d6c44157ddbe6d7ee2defc http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5391334ba245181b6f8515e53607a693 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cc9194ada9e8955fc8da26bded2becb4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b4f749ef52c0cfa98364152d7c6a5b5 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-689 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56938 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-689 |
filingDate |
2004-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4fa05659f431c4bad7aea04da98e080 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_080d88c2885fdc30f7d5c32b8be441bc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_987e02d38990dde3a127e32705426f99 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8251f581b43fa8f3a585fa6e4bb518c |
publicationDate |
2004-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2004099444-A2 |
titleOfInvention |
Diagnostic methods |
abstract |
A method for detecting a strain of Staphylococcus aureus which has reduced susceptibility to vancomycin and/or teicoplanin, said method comprising detecting the level of expression of an fmtB/mrp or mrp-homologue gene or a variant thereof within said strain and relating that to the susceptibility or resistance of the strain to vancomycin and/or teicoplanin. Detection of expression is suitably carried out using immunological to detect the gene product or molecular methods to detect RNA constructs. The method allows for the detection of strains of Staphylococcus aureus that are homogeneously or heterogeneously intermediate to vancomycin and/ or teicoplanin. |
priorityDate |
2003-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |